Visit https://www.peervoice.com/NTG860 to view the entire programme with slides. After completing “Transforming the Treatment of Acute Hepatic Porphyria”, participants will be able to: Summarise key findings from a published study evaluating the efficacy and safety of a treatment for acute hepatic porphyria (AHP); Evaluate clinical evidence in terms of safety and efficacy, as well as study design, population, and patient-reported outcomes; Discuss the implications of these data for the management of patients with AHP.